(MedPage Today) — The FDA approved gepotidacin (Blujepa), an oral option for the treatment of uncomplicated urogenital gonorrhea among patients ages 12 years and older, GSK announced on Thursday.
Gepotidacin is the first in a new class of antibiotics…
Source link : https://www.medpagetoday.com/infectiousdisease/stds/118972
Author :
Publish date : 2025-12-11 22:02:00
Copyright for syndicated content belongs to the linked Source.
